REGULATORY
Label Revisions Ordered for 5 APIs, Hitting Slew of Amoxicillin/Chlorhexidine Products
The Ministry of Health, Labor and Welfare (MHLW) on October 17 ordered label revisions for five APIs, including the antibiotic amoxicillin and antiseptic chlorhexidine contained in a raft of single-agent and combination products. For over 20 ethical drug products containing…
To read the full story
Related Article
- Trazenta, Amoxicillin and Others under PMDA Risk Review
September 26, 2017
REGULATORY
- Government Unveils Four-Chapter Outline for 2026 Honebuto
June 26, 2026
- LDP, Ishin Leave Chuikyo Reform to Party Negotiators after Talks Stall
June 26, 2026
- Japan Targets Global-Level Growth for Domestic Patented Drug Market
June 25, 2026
- Paxlovid, Awiqli Braced for NHI Price Cuts after CEAs
June 25, 2026
- Drug Pricing to Be Applied to Oncolys Oncolytic Virus Therapy
June 25, 2026
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…





